Search - tctmd.com

Displaying 161 - 180 of 228

Sort: Relevancy | Date

News Conference News EuroPCR 2014

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

Caitlin E. Cox

May 20, 2014

Presentation ACC 2014

Two-Year Outcome of a Randomized Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer

Presenter: Masahiro Natsuaki

March 31, 2014

News Conference News ACC 2014

NEXT at 2 Years: Nobori DES Still Noninferior to Xience/Promus

Jason Kahn

March 31, 2014

Presentation CIT 2014

A Prospective, Multicenter, Randomized Trial of YINYI Polymer-Free Paclitaxel-Eluting Stent vs. Durable Polymer Sirolimus-Eluting Stent in the Treatment of Coronary Artery Disease

Presenter: Yong Huo

March 22, 2014

News Daily News

DUTCH PEERS Published: Third-Generation Zotarolimus, Everolimus Stents Equivalent

February 12, 2014

News Daily News

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

January 01, 2014

News Daily News

Second-Generation DES the Better Choice for STEMI Patients

December 09, 2013

News Industry News

Boston Scientific Receives FDA Approval For Promus Premier™ Everolimus-Eluting Platinum Chromium Coronary Stent System

November 24, 2013

Presentation TCT 2013

Comparison of Polymer-Free BioFreedom™ Stents with Durable Polymer Taxus Liberté™ Stents: 4-Year Results from the BioFreedom First-In-Man Trial

Presenter: 208788|Ricardo Costa

October 29, 2013

Presentation TCT 2013

Biodegradable-Polymer Drug-Eluting Stents versus Bare Metal Stents versus Durable-Polymer Drug-Eluting Stents : A Systematic Review and Bayesian Approach Network Meta-Analysis

Presenter: Si-Hyuck Kang

October 29, 2013

News Industry News

New Study Compares Two Newer Generation Drug-Eluting Stents with Biocompatible and Biodegradable Polymers

October 29, 2013

Presentation TCT 2013

Vascular Responses of Contemporary Durable Polymer DES, Bioabsorbable Polymer DES, Polymer-free DES and Fully Bioresorbable Scaffolds: Can Meaningful Differences in Vascular...

Presenter: Renu Virmani

October 27, 2013

Presentation TCT 2013

Based on the Current Data, Durable Polymer DES Offer Early and Late Clinical Advantages!

Presenter: Sripal Bangalore

October 27, 2013

News Daily News

Study Challenges Guidelines Regarding Delay for Noncardiac Surgery After PCI

L.A. McKeown

October 11, 2013

News Daily News

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

Yael L. Maxwell

September 20, 2013

News Industry News

Boston Scientific Concludes Enrollment In Randomized, Multicenter, Pivotal Study Of SYNERGY™ Coronary Stent System

September 12, 2013

News Conference News EuroPCR 2013

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Caitlin E. Cox

May 29, 2013

News Industry News

Boston Scientific Promus PREMIER™ And SYNERGY™ Drug-Eluting Stent Systems Provide Exceptional Safety And Efficacy Data

May 22, 2013

Presentation

Biodegradable Polymer BES vs. Durable Polymer EES: A Randomized, Controlled, Non-inferiority Trial

Presenter: 221201|Masahiro Natsuaki

May 08, 2013

News Daily News

NEXT Published: Biodegradable Polymer BES Shows Noninferiority to EES

Yael L. Maxwell

May 08, 2013

Advertisement

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

Two-Year Outcome of a Randomized Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer

NEXT at 2 Years: Nobori DES Still Noninferior to Xience/Promus

A Prospective, Multicenter, Randomized Trial of YINYI Polymer-Free Paclitaxel-Eluting Stent vs. Durable Polymer Sirolimus-Eluting Stent in the Treatment of Coronary Artery Disease

DUTCH PEERS Published: Third-Generation Zotarolimus, Everolimus Stents Equivalent

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

Second-Generation DES the Better Choice for STEMI Patients

Boston Scientific Receives FDA Approval For Promus Premier™ Everolimus-Eluting Platinum Chromium Coronary Stent System

Comparison of Polymer-Free BioFreedom™ Stents with Durable Polymer Taxus Liberté™ Stents: 4-Year Results from the BioFreedom First-In-Man Trial

Biodegradable-Polymer Drug-Eluting Stents versus Bare Metal Stents versus Durable-Polymer Drug-Eluting Stents : A Systematic Review and Bayesian Approach Network Meta-Analysis

New Study Compares Two Newer Generation Drug-Eluting Stents with Biocompatible and Biodegradable Polymers

Vascular Responses of Contemporary Durable Polymer DES, Bioabsorbable Polymer DES, Polymer-free DES and Fully Bioresorbable Scaffolds: Can Meaningful Differences in Vascular...

Based on the Current Data, Durable Polymer DES Offer Early and Late Clinical Advantages!

Study Challenges Guidelines Regarding Delay for Noncardiac Surgery After PCI

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

Boston Scientific Concludes Enrollment In Randomized, Multicenter, Pivotal Study Of SYNERGY™ Coronary Stent System

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Boston Scientific Promus PREMIER™ And SYNERGY™ Drug-Eluting Stent Systems Provide Exceptional Safety And Efficacy Data

Biodegradable Polymer BES vs. Durable Polymer EES: A Randomized, Controlled, Non-inferiority Trial

NEXT Published: Biodegradable Polymer BES Shows Noninferiority to EES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content